Volume : 10, Issue : 02, February – 2023
Title:
23.A RARE CASE OF NITROFURANTIOIN INDUCED AUTOIMMUNE LIKE HEPATITIS
Authors :
Aleena Elizabeth Mathew , Dr. S.K Mathew , Dr. Asok Kumar B , Dr. Amala Maria Saji
Abstract :
The class of nitro furan antibiotics includes Nitrofurantoin, an agent primarily used to treat urinary tract infections. It is efficacious as it can attain therapeutic concentration in urine and elicit both bactericidal and bacteriostatic activity against both gram positive and gram-negative organisms. Hence proving its efficacy in treating lower urinary tract infections. It also shows very less resistance and although widely used it also has its side effects like rashes, loss of appetite, dizziness, fever, diarrhoea,,. It can also cause adverse reactions like pulmonary toxicity, hepatic toxicity, haemolytic anaemia but the incidence of such events is rare. Even though the occurrence of hepatotoxicity is rare, to overlook monitoring for possible liver injury may prove fatal. As nitrofurantoin is one of the most common drugs behind drug induced liver injury checking for any possible liver injury becomes crucial. The drug is also capable of presenting autoimmune features like presence of auto antibodies and may trigger autoimmune hepatitis and if not discontinued in time can lead to complications like cirrhosis or liver failure. Occurrence of drug induced autoimmune hepatitis is unusual and can considered as a phenotype of the drug. Differentiating between a drug induced mimicry of autoimmune features and idiopathic autoimmune hepatitis is very difficult. But if it is drug induced liver injury mimicking autoimmune hepatitis, discontinuation of the drug can help resolve the event.
Here we present a case of a 56-year-old woman who was on a long-term treatment with nitrofurantoin against recurrent urinary tract infection for over a period of about 1 year. She was admitted with complains of yellowish discoloration of eyes and skin, dark coloured urine, abdominal pain, vomiting, edema on both legs and history of weight loss. She also had highly elevated liver enzymes. She also showed presence of autoantibody. However, her symptoms resolved on discontinuation of nitrofurantoin, liver enzymes reduced to a normal range and the patient showed response to treatment with corticosteroids and with no relapse on follow up.
KEY WORDS: NITROFURANTOIN, AUTOIMMUNE HEPATITIS, DRUG INDUCED AUTOIMMUNE LIKE HEPATITIS, URINARY TRACT INFECTION, AUTOANTIBODIES
Cite This Article:
Please cite this article in press Aleena Elizabeth Mathew et al, A Rare Case Of Nitrofurantioin Induced Autoimmune Like Hepatitis., Indo Am. J. P. Sci, 2023; 10 (02).
Number of Downloads : 10
References:
2) Squadrito FJ, del Portal D. Nitrofurantoin.. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29262089.
3) Gardiner, Bradley J et al. “Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.” Australian prescriber vol. 42,1 (2019): 14-19.
4) McOsker, C C, and P M Fitzpatrick. “Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.” The Journal of antimicrobial chemotherapy vol. 33 Suppl A (1994): 23-30.
5) Shakti, Laishram, and Balaji Veeraraghavan. “Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario.” Indian journal of medical microbiology vol. 33,4 (2015): 477-81. doi:10.4103/0255-0857.167350
6) Hoener, B et al. “Nitrofurantoin produces oxidative stress and loss of glutathione and protein thiols in the isolated perfused rat liver.” Pharmacology vol. 38,6 (1989): 363-73. doi:10.1159/000138559
7) Li, Hui et al. “Electron Deficiency of Nitro Group Determines Hepatic Cytotoxicity of Nitrofurantoin.” Chemical research in toxicology vol. 32,4 (2019): 681-690. doi:10.1021/acs.chemrestox.8b00362
8) Rossi, L et al. “Nitrofurantoin-mediated oxidative stress cytotoxicity in isolated rat hepatocytes.” Biochemical pharmacology vol. 37,16 (1988): 3109-17. doi:10.1016/0006-2952(88)90308-5
9) Czaja, Albert J. “Drug-induced autoimmune-like hepatitis.” Digestive diseases and sciences vol. 56,4 (2011): 958-76. doi:10.1007/s10620-011-1611-4
10) Sakaan, Sami A et al. “Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.” Southern medical journal vol. 107,2 (2014): 107-13. doi:10.1097/SMJ.0000000000000059
11) Abboud, Gebran, and Neil Kaplowitz. “Drug-induced liver injury.” Drug safety vol. 30,4 (2007): 277-94. doi:10.2165/00002018-200730040-00001
12) Bashir, Anam, et al. “Liver Toxicity.” StatPearls, StatPearls Publishing, 14 August 2022.
13) Claussen, Karin et al. “How Common Are Pulmonary and Hepatic Adverse Effects in Older Adults Prescribed Nitrofurantoin?.” Journal of the American Geriatrics Society vol. 65,6 (2017): 1316-1320. doi:10.1111/jgs.14796
14)Björnsson, Einar et al. “Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.” Hepatology (Baltimore, Md.) vol. 51,6 (2010): 2040-8. doi:10.1002/hep.23588
15) Gatselis, Nikolaos K et al. “Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.” World journal of gastroenterology vol. 21,1 (2015): 60-83. doi:10.3748/wjg.v21.i1.60
16) Drug-Induced Liver Injury — Types and Phenotypes Jay H. Hoofnagle, M.D., and Einar S. Björnsson, M.D.
17) Björnsson, Einar, and Rolf Olsson. “Outcome and prognostic markers in severe drug-induced liver disease.” Hepatology (Baltimore, Md.) vol. 42,2 (2005): 481-9. doi:10.1002/hep.20800
18) Reuben, Adrian. “Hy’s law.” Hepatology (Baltimore, Md.) vol. 39,2 (2004): 574-8. doi:10.1002/hep.20081
19)Bessone, Fernando et al. “Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.” Archives of toxicology, 10.1007/s00204-022-03419-7. 22 Nov. 2022, doi:10.1007/s00204-022-03419-7
20) Acharya, Gyanendra K et al. “Autoimmune Hepatitis: Diagnostic Dilemma When It Is Disguised as Iron Overload Syndrome.” Journal of clinical and experimental hepatology vol. 7,3 (2017): 269-273. doi:10.1016/j.jceh.2017.03.006
21)Björnsson, Einar Stefan et al. “Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 15,10 (2017): 1635-1636.
22) Covelli, Claudia et al. “Pathology of autoimmune hepatitis.” Pathologica vol. 113,3 (2021): 185-193. doi:10.32074/1591-951X-241
23) Zen, Yoh, and Matthew M Yeh. “Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury.” Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 31,6 (2018): 965-973. doi:10.1038/s41379-018-0013-y